# AVA Sciences-FMTC

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ava-sciences-fmtc

- Industry: Medical Devices & Equipment
- Headquarters: Zurich, Switzerland
- Website: www.avawomen.com
- Total disclosed funding: $42M
- Latest round: Series B (May 29, 2018)
- Investors on record: 9

## About

AVA Sciences-FMTC GmbH offers advanced fertility tracking solutions through its innovative Ava bracelet, empowering women to effectively manage their reproductive health.Founded in 2014 and headquartered in Zurich, Switzerland, AVA Sciences-FMTC GmbH focuses on developing fertility tracking technologies. The company has received investment funding and has participated in 4 deals, culminating in its most recent funding round, Series B, where they raised USD 30.00 mn in July 2022, with investors including Alpana Ventures and Credit Suisse Entrepreneur Capital. The company was acquired by FemTec Health, Inc. in July 2022, integrating their offerings into broader health solutions.AvaWomen specializes in providing innovative fertility tracking solutions, primarily through its flagship product, the Ava bracelet. This wearable device is designed to be worn during sleep and tracks five physiological signals using advanced machine learning algorithms. The bracelet analyzes the collected data to identify the five most fertile days within a menstrual cycle, helping users manage their reproductive health effectively. Ava's target customer base includes women seeking to conceive, particularly those who have previously faced challenges with fertility. The company serves a diverse geographical market, including North America and Europe, catering to the needs of individuals and couples looking for data-driven support in their journey toward pregnancy.AvaWomen generates revenue through direct-to-consumer sales of its Ava bracelet, which is often reimbursed by numerous health insurance providers. The company's transactional structure revolves around a B2C model, where users purchase the device online, facilitated by an informative platform that enhances user engagement and education regarding fertility tracking. The Ava bracelet is marketed as a clinically tested product, providing personalized fertility insights that aim to improve the likelihood of conception. The company leverages partnerships with employers and health providers to integrate its solutions into broader reproductive health plans, creating additional revenue streams through these collaborations. Specific pricing plans for the Ava bracelet and associated services are set strategically to ensure accessibility while reflecting the product's advanced technology and clinical validation.Following the acquisition in July 2022, AVA Sciences-FMTC GmbH plans to enhance its product offerings by integrating services with Bolttech Digital Brokerage Singapore Pte. Ltd. to be provided to Ava users and subscribers of Awesome Woman. This strategic move is aimed at expanding their market reach and diversifying their services. The company is targeting further geographic expansion into additional markets in Europe and North America by the end of 2023.

## Funding rounds

- Series B, May 29, 2018, $30M — Credit Suisse Entrepreneur Capital, b2venture, Privilege Management SA, Alpana Ventures
- Series A, Nov 15, 2016, $9.7M — Zürcher Kantonalbank, BOV Capital, Swisscom Ventures, Global Sources Ltd., Polytech Ventures
- Seed, Nov 12, 2015, $2.6M — Zürcher Kantonalbank, Swisscom Ventures

## Investors

- Zürcher Kantonalbank — Seed, Series A
- Swisscom Ventures (https://capitalatlas.ai/funds/swisscom-ventures) — Seed, Series A
- BOV Capital (https://capitalatlas.ai/funds/bov-capital) — Series A
- Global Sources Ltd. — Series A
- Polytech Ventures (https://capitalatlas.ai/funds/polytech-ventures) — Series A
- Credit Suisse Entrepreneur Capital (https://capitalatlas.ai/funds/credit-suisse-entrepreneur-capital) — Series B
- b2venture (https://capitalatlas.ai/funds/b2venture) — Series B
- Privilege Management SA (https://capitalatlas.ai/funds/privilege-management-sa) — Series B
- Alpana Ventures (https://capitalatlas.ai/funds/alpana-ventures) — Series B